NCT03252145

Brief Summary

This study will be a 4 to 6 week randomized, controlled, assessor blinded, trial comparing a negative pressure massage device (intervention group), to the standard manual lymph drainage massage (control group), in breast cancer patients with chronic upper extremity lymphedema.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
28

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2017

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 10, 2017

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 17, 2017

Completed
3 months until next milestone

Study Start

First participant enrolled

October 31, 2017

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2020

Completed
11 months until next milestone

Results Posted

Study results publicly available

January 8, 2021

Completed
Last Updated

January 15, 2021

Status Verified

December 1, 2020

Enrollment Period

2.3 years

First QC Date

August 10, 2017

Results QC Date

November 13, 2020

Last Update Submit

January 13, 2021

Conditions

Outcome Measures

Primary Outcomes (2)

  • Recruitment Rates

    The recruitment rate is defined as the number of women who were screened and then enrolled on the study divided by the the total number of women screened overall.

    At 4 weeks

  • Percentage of Participants Who Completed All Study Visits

    Retention rates for both arms of this study were evaluated. The numbers of women who completed the study will be recorded. Reasons for drop out will be ascertained.

    At 4 weeks

Secondary Outcomes (28)

  • Mean Limb Volume

    At Baseline

  • Mean Limb Volume

    At 4 weeks

  • Mean Lymphedema Index (L-DEX®) Ratio Scores

    At Baseline

  • Mean L-DEX® Scores

    At 4 weeks

  • Mean Skin Induration Score

    At Baseline

  • +23 more secondary outcomes

Study Arms (2)

Negative Pressure

EXPERIMENTAL

PhysioTouch (negative pressure massage) treatment 3 times a week for 4 weeks to the lymphedematous upper limb

Device: PhysioTouch

Manual Lymph Drainage

ACTIVE COMPARATOR

Manual lymph drainage (MLD) treatment 3 times a week for 4 weeks to the lymphedematous upper limb

Other: Manual Lymph Drainage (MLD)

Interventions

The PhysioTouch is a hand-held device that administers negative pressure under the treatment head, and gently pulls the underlying skin and subcutaneous tissue into the suction cup. This suction produces a stretch to the skin and in the subcutaneous tissue space. This action is thought to facilitate lymphatic flow from the interstitium into the lymphatic vessels, and mobilizes the superficial fascia.

Negative Pressure

MLD is a practitioner-applied manual massage technique designed to decrease limb volume in patients with lymphedema by enhancing movement of lymph fluid, resulting in reductions in interstitial fluid.

Manual Lymph Drainage

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • To be included women must be:
  • Be over 18 years of age;
  • Have had cancer treatment that included a surgical procedure, radiation therapy (RT), and/or chemotherapy (CTX);
  • Have completed active cancer treatment at least 1 year prior to study enrollment;
  • Have been diagnosed with lymphedema (LE) at least one year prior to study enrollment;
  • Have arm lymphedema on one side only;
  • Have confirmed LE based on bioimpedance measurements with an L-Dex® score of \>7.1 (note - this is very mild lymphedema);
  • Have stable arm LE. LE will be considered "stable" if during the 3 months prior to study enrollment there was no arm infection requiring antibiotics, no change in ability to perform activities of daily living related to LE, and no subjective report of significant persistent changes in limb volume;
  • Be mentally and physically able to participate in the study;
  • Be able to attend the sessions at the University of California, San Francisco (UCSF) Parnassus campus;
  • Read and understand English;
  • Be able to understand a written informed consent document and the willingness to sign it

You may not qualify if:

  • Women cannot have:
  • Bilateral upper extremity LE;
  • Current infection or lymphangitis involving the affected arm;
  • Current recurrence of their breast cancer (BC) (local or distant)
  • Pre-existing LE prior to their BC diagnosis;
  • A condition that precludes measurement of LE using Bioimpedance Spectroscopy (BIS), including pregnancy;
  • Current venous thrombosis in either upper extremity or be on current anticoagulant therapy;
  • Extremity edema due to heart failure

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of California San Francisco

San Francisco, California, 94158, United States

Location

Related Publications (1)

  • Lampinen R, Lee JQ, Leano J, Miaskowski C, Mastick J, Brinker L, Topp K, Smoot B. Treatment of Breast Cancer-Related Lymphedema Using Negative Pressure Massage: A Pilot Randomized Controlled Trial. Arch Phys Med Rehabil. 2021 Aug;102(8):1465-1472.e2. doi: 10.1016/j.apmr.2021.03.022. Epub 2021 Apr 16.

MeSH Terms

Conditions

LymphedemaNeoplasm Metastasis

Interventions

Manual Lymphatic Drainage

Condition Hierarchy (Ancestors)

Lymphatic DiseasesHemic and Lymphatic DiseasesNeoplastic ProcessesNeoplasmsPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

MassageTherapy, Soft TissueMusculoskeletal ManipulationsComplementary TherapiesTherapeuticsDrainagePhysical Therapy ModalitiesRehabilitation

Results Point of Contact

Title
Betty Smoot, DPTSc, PT
Organization
University of California, San Francisco

Study Officials

  • Betty Smoot, DPTSc, MAS

    University of California, San Francisco

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 10, 2017

First Posted

August 17, 2017

Study Start

October 31, 2017

Primary Completion

January 31, 2020

Study Completion

January 31, 2020

Last Updated

January 15, 2021

Results First Posted

January 8, 2021

Record last verified: 2020-12

Data Sharing

IPD Sharing
Will not share

Locations